SaNOtize’s Nitric Oxide Nasal Spray is available as a medical device in Thailand, Singapore, Hong Kong, South Africa, Malaysia, Cambodia, Germany (branded as VirX^TM), Israel, Indonesia and Bahrain (branded as enovid^TM).

It is also available in India, with prescription, under the name FabiSpray.

It is not yet approved for sale in Canada or the United States.

VirX^TM and enovid^TM are identical formulations based on our NORS^TM (Nitric Oxide Releasing Solution) platform technology. They have the same active ingredients and mechanisms of action as those nasal therapeutics used in our clinical trials.